COMMERCIAL & MEDICAL
Transforming the standard of care
Commercial and medical teams play a pivotal role in ensuring innovative therapies reach the patients who need them and enabling evidence-based care. Today’s commercial and medical leaders are expected to deliver greater business impact in increasingly dynamic environments: accelerating patient access, maximising launch success, and enabling seamless customer engagement across digital and face-to-face channels.
The challenge is to develop global strategies that meet local needs and establish clarity in a shared agenda, enabling effective global-local and cross-functional execution. Investing in building a fit-for-purpose global-local model, and the structures to maintain it, is a prerequisite for delivering commercial and medical excellence at scale.
At Biobridge Partners, we help commercial and medical leaders through strategy and execution: developing practical go-to-market strategies, clarifying patient and HCP needs, and enabling robust operating models for sustainable performance. We work shoulder-to-shoulder with commercial and medical organisations to help navigate complexity, make choices, and drive progress. Explore how we can help you progress with confidence.
Navigate complexity
Shifting competitive dynamics, evolving evidence standards, complex care pathways, and the rise of direct-to-patient and digital solutions are reshaping the landscape for commercial and medical leaders. Internally, organisations must coordinate progress across headquarter and regions, across functions, and across customer touchpoints. We help make sense of this complexity by leveraging proven methodologies for identifying and addressing internal and external needs.
Examples of projects where we successfully helped commercial and medical leaders navigate complexity:
- Mapping of cardiometabolic patient care pathways and unmet needs
- Assessing the diagnostic testing landscape for hsCRP across European markets
- Benchmarking global omnichannel customer engagement capabilities against peers

Assessed hsCRP testing landscape readiness across European markets, identifying critical gaps, and recommending targeted TA development initiatives.
Read More
Clarifying Medical value drivers across functions and roles and structuring strategic choices for delivering society engagement, congress engagement, and RWE.
Read More
Developing global TA strategy for reproductive medicine setting future direction for the portfolio as approved by the client’s executive management and Board.
Read More
Designing global Digital Hub operating model, delivering content and automation services to all markets globally.
Read MoreMake choices
Commercial and medical leaders face high-stakes decisions that shape patient access, product success, and long-term value creation – from positioning and differentiation to evidence planning and customer engagement. We help you make confident, high-stakes choices by structuring options, clarifying trade-offs, and aligning key stakeholders. Our approach is pragmatic and action-oriented, ensuring that choices are grounded in your strategic and operational reality.
Examples of projects where we successfully helped commercial and medical leaders make choices:
- Growth strategy and repositioning of a biologic facing intensifying competition
- Establishing a global content hub to deliver content excellence and lower costs
- Defining Medical Excellence framework with clear choices and deselections
Drive progress
Progress in commercial and medical functions depends on more than the right strategy – it is about mobilising people, embedding new ways of working, and ensuring change is truly adopted. Success relies on securing buy-in, equipping teams for new challenges, and translating ambition into tangible results at every level. We work closely with you to design actionable strategies and execution frameworks to deliver measurable impact and progress that compounds over time.
Examples of projects where we successfully helped commercial and medical leaders drive progress:
- Navigating omnichannel transformations in the strategy office
- Embedding digital and omnichannel capabilities across commercial and medical teams
- Piloting commercial excellence initiatives in high-growth markets

Moving from omnichannel ambition to execution via fit-for-purpose global-local operating model design and roll-out across markets.
Read More
Improving the standard of care with a leading immunology brand and identifying where the next wave of patient and commercial value is unlocked.
Read MoreStart a conversation with our team
Whether you are seeking informal sparring, navigating a specific challenge,or exploring a collaboration, we would love to hear from you.
Meet the experts
Our team of life science strategists blends international experience and backgrounds from MDs, PhDs, and top-tier strategy consulting. We engage with a structured and collaborative approach to develop practical solutions to complex problems. Meet our team of experienced life science consultants.
- Partners
- Board of Directors
- Team
Daniel works with life science executives to design strategies, operating models, and transformation programs. He brings both functional depth and board-level perspectives, helping senior leaders navigate complexity and make clear choices. He formerly led the life science practice at Deloitte Denmark.
Book Meeting
Jonas is a life science strategist supporting executives drive progress across the value chain. He is an expert in bridging strategy and execution via global operating model design and transformation rooted in strategic objectives. He engages with structured top-down thinking and a pragmatic and collaborative approach to mobilise organizations and make things happen.
Book Meeting
Jens is a seasoned strategy advisor with 30 years of experience in management consulting. Former Head of Monitor Deloitte Denmark, he brings deep expertise in shaping corporate agendas, TA strategies, operating model design, digital and AI value creation, and M&A for leading global corporations.
Book Meeting
Nicolai is a seasoned management consultant with over 20 years of experience working with C-suite executives at Danish C25 companies. He has held several leadership roles, including Senior Partner and Nordic Lead for Monitor Deloitte and Managing Director of Accenture Denmark.
Book Meeting
Alexander has 25 years of experience as an international strategy and communications advisor, supporting C-suite leaders at global biopharmaceutical companies on life science branding, digital strategy, and commercialisation. He is founder of the strategic advisory firm &Now, and co-founder of the communications firm REPUTATION.
Book Meeting
Camilla brings nearly 30 years of global pharmaceutical leadership, holding senior roles at AstraZeneca, Novartis, Allergan, Alexion, Theramex, and most recently EVP, President, International at Ascendis. Her career spans global commercial and executive leadership roles.
Book Meeting
Florian combines experience from strategy consulting and the pharmaceutical industry with a background in Economics from CBS. Recognised for structured problem-solving and a collaborative approach, he supports clients on strategic topics across the pharmaceutical value chain.
Book Meeting
Johannes has 7+ years of experience in strategy consulting and has strong expertise in TA strategy, organisational transformations, operating model design, and commercial launch planning.
Johannes holds an M.Sc. in Economics from the University of Copenhagen.
Book Meeting
Mette blends medical expertise with strategic experience as a medical doctor and former strategy consultant. Before joining Biobridge Partners, she worked at Bain & Company and LEO Innovation Lab. She focuses on cross-functional engagement in medical and commercial functions in pharma.
Book Meeting
Alfred is a seasoned life science strategy consultant with a background from Monitor Deloitte and 3+ years’ experience helping clients articulate and assess strategies, develop strategic options, and translate strategic intent into actionable plans.
Book Meeting
Josephine holds M.Sc. degrees in Biochemistry (University of Copenhagen) and Bioscience Enterprise (UCL), combining life science expertise with business. She has prior consulting experience at Bain & Company, advising clients across multiple industries.
Book Meeting
Amadou brings a cross-disciplinary background in Biotechnology and Business Administration. He has experience in strategic projects spanning the full pharmaceutical value chain, from early research to development and commercial strategy.
Book Meeting
Daniell leads marketing at Biobridge Partners, helping shape the firm’s positioning, narrative, and go-to-market execution across brand and thought leadership. He brings a background in design and concept development, including experience as a product designer on the health app SELF and 3 years leading marketing at BASE life science.
Book Meeting
Caroline brings a strong international background and a passion for life science and its potential for impact. She is pursuing a B.Sc. in International Business at CBS, with a growing focus on strategy, market access, and business development in the life sciences sector.
Book Meeting
Anton is a life science strategy consulting intern with a cross-disciplinary background in molecular medicine and business administration. He has hands-on experience in gene and cell therapy research and focuses on translating scientific innovation into real-world impact through strategic insight.
Book Meeting
Bertram brings prior experience in life science and a strong interest in strategy and business development. He is pursuing a B.Sc. in International Business at CBS, with a focus on market entry and growth topics within the life sciences sector.
Book Meeting